[vc_row][vc_column width=”1/3″][vc_single_image image=”11014″ img_size=”200 x 200″ alignment=”center”][/vc_column][vc_column width=”1/3″][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][vc_column_text]
In this All-Member and all-community webinar for August 2016, CAC2 welcomes Drs. Michael Trigg, Brigid Bradley-Garelik, and Greg Plautz from Bristol-Myers Squib, speaking on the clinical trial process.
These three esteemed industry experts provided an overview of the clinical trial process, particularly from an industry-sponsored trial perspective and cover topics such as clinical trial designs, different required FDA phases of drug development, data monitoring committees, general principles of pediatric trials and special considerations of pediatric trials, industry obligations to pediatrics and personalized medicine.
This presentation was not recorded.
[/vc_column_text][vc_empty_space][/vc_column][/vc_row]
